Reference entry

Bremelanotide

Also listed as Vyleesi

Read the scope, examine the source, and keep your own question alongside the evidence.

Status labels apply within the product, route, and use described below. Read the limitations alongside that scope.

Scoped product status: Approved product
Evidence label: Randomized evidence

Status as of 2026-10-27

Reference fields

Sources for these fields

Product and use: Vyleesi: eligible premenopausal women with distressing acquired generalized low-desire disorder.
Route context: Subcutaneous injection.
Mechanism: Melanocortin-receptor agonist.
Evidence: Randomized trials.
Limitations: Exclude medical, relationship and drug causes; not performance enhancement.
Safety: Uncontrolled hypertension or known cardiovascular disease: contraindicated.

From a report to your question

Read a statement about what was not demonstrated with attention to the question that was actually tested. Look for the outcome definition, the comparison, and the range of interpretations the report leaves open. If a summary turns uncertainty into a firm negative claim, ask which part of the evidence supports that step. Equally, an unresolved question does not provide positive support for the opposite conclusion. Write down what the analysis could distinguish and what remains unsettled, rather than forcing the result into a simple yes or no.

Questions to consider

What question does the report say its analysis could address?
Which possible interpretations remain compatible with the evidence presented here?
Is the summary preserving uncertainty or converting it into a stronger claim?

Sources

These references support the fields as a group. Follow a source to check the original wording and its scope.

VYLEESINLM · Checked 2026-10-27
Kingsberg trialsPubMed · Checked 2026-10-27

Continue reading

Reading topics: Sexual health. These organize the library and do not describe recommended uses.

Educational reference information. No clinician review is claimed. This entry does not provide personal medical advice.